Amarin Corp Plc (AMRN)

[ratna1]

Dear Jesse, yor arguments are sublimely convincing and your expertise in the MoA of DHA and EPA unmatched.ThereforeI wold like to implore you to present your expertise and thoughts to the adressees you mentioned directly in your own name and with your full credentials as you laid them out out in your FDA AdHoc testimonial!

If I may I would like to make one more suggestion:

IF(!?!) Reddy or Hikma in fact presented an estimated income of 700+ million$ p.a. through their "generic Vascepa" product at JPM practically parallel to the first day in court it is obvious that such a projected turnover can never ever be achieved by a limited niche indication for pancreatitis and for a timeframe up to 12 weeks of prescriptions.
I hope you could include that slide of Reddy's presentation.

As much as I appreciate BioB's exuberance and excitability I fear the persuasivness of yur arguments might get tainted if the receipients might have felt pressured by BioB's proactive endeavours of the past.
I would certainly present your ideas myself but would not be able to answer any further questions if the arguments would raise interest to explore the issue.
Moreover in the US I am only able to present as a Dr.honoris causa so far less weighty than your CV.
Please give it some thought. I feel you may hold the keys for an immediate ruling in our favour
With warm regards,
Ratna